Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Dongqing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3369-5972; OpenAlex author ID A5100670777. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Radiotherapy followed by metformin neoadjuvant therapy drives superior pancreatic cancer ferroptosis and augments anti-tumor immunity. Co-author DOI 10.1016/j.fmre.2025.12.010↗
  2. Hallmarks of perineural invasion in pancreatic ductal adenocarcinoma: new biological dimensions. Last author DOI 10.3389/fonc.2024.1421067↗
  3. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hy… First author DOI 10.3892/or.2014.3298↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiang Liao · 2 shared papers, 2024–2026 · strength 0.58
  2. Haitao Zhu · 2 shared papers, 2014–2026 · strength 0.32
  3. Yaquan Sun · 1 shared paper, 2024 · strength 0.31
  4. Xin Wang · 1 shared paper, 2026 · strength 0.27
  5. Wenjin Xu · 1 shared paper, 2026 · strength 0.27
  6. Genbao Shao · 1 shared paper, 2014 · strength 0.04
  7. Yanfang Liu · 1 shared paper, 2014 · strength 0.04
  8. Zhaoliang Su · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.